Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The specific aim of the proposed study is to conduct a pilot study involving 160 critically-ill lean and obese patients enrolled at 9 sites in Canada, the United States of America, Belgium and France in order to:
Specific Aims
- Confirm that we can achieve a clinically significant difference in calorie and protein intake between the two intervention groups.
- Estimate recruitment rate i.e. number of eligible and enrolled patients per month per site.
Evaluate the safety, tolerance, and logistics around providing supplemental PN in the study population in the context of a multicenter trial, e.g.
- To ensure adequate glycemic control in both groups.
- To ensure that the other metabolic consequences of the feeding strategies are minimized.
- To establish adequate compliance with study protocols and completion of case report forms
A secondary aim of this pilot study will be:
• To explore the effect of differential effects of calorie and protein delivery on muscle and mass function.
| Condition | Intervention | Phase |
|---|---|---|
|
Critical Illness Acute Respiratory Failure |
Dietary Supplement: Olimel (5.7%E / N9E) |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients: The TOP UP Trial (Pilot) |
- Amount of calories and protein received [ Time Frame: 28 days ] [ Designated as safety issue: No ]
- 60 day mortality [ Time Frame: 60 days ] [ Designated as safety issue: No ]
- ICU mortality [ Time Frame: 28 days ] [ Designated as safety issue: No ]
- Development of ICU-acquired infections [ Time Frame: 28 days ] [ Designated as safety issue: No ]
- Hospital mortality [ Time Frame: 60 days ] [ Designated as safety issue: No ]
- Duration of ICU stay [ Time Frame: 60 days ] [ Designated as safety issue: No ]
- Multiple organ dysfunction (SOFA and PODS) [ Time Frame: 28 days ] [ Designated as safety issue: No ]Sequential Organ Failure Assessment(SOFA) Persistant Organ Dysfuntion Score (PODS)
- Duration of mechanical ventilation. [ Time Frame: 28 days ] [ Designated as safety issue: No ]
- SF36 [ Time Frame: 60 days ] [ Designated as safety issue: No ]Survival and health-related quality of life
- Duration of hospital stay [ Time Frame: 60 days ] [ Designated as safety issue: No ]
- Muscle Function - Ultrasounds [ Time Frame: 28 days ] [ Designated as safety issue: No ]Ultrasounds of the femoral quadricepe will be done to assess the muscle layer thickness (MLT) of the M. vastus intermedius and M rectus femoris.
- Muscle Function - CT Scans [ Time Frame: 28 days ] [ Designated as safety issue: No ]CT scans done for clinical reasons done at the 3rd lumbar vertebrae will be used to assess muscle mass.
- Muscle Function - Hand-Grip Strength [ Time Frame: ICU Discharge ] [ Designated as safety issue: No ]At ICU discharge, a hand-grip strength test will be done.
- Muscle Function - 6 min walk test [ Time Frame: ICU Discharge ] [ Designated as safety issue: No ]At ICU discharge, a 6 min walk test will be done.
| Estimated Enrollment: | 160 |
| Study Start Date: | June 2011 |
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Enteral Nutrition plus Parenteral Nutrition
Enteral nutrition with the addition of parenteral supplementation (Olimel 5.7%E/N9E).
|
Dietary Supplement: Olimel (5.7%E / N9E)
OLIMEL(Amino Acids, Dextrose, Lipids, with / without Electrolytes) is indicated for parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.
|
| No Intervention: Enteral Nutrition Only |
Detailed Description:
Background
Critically ill patients are often hypermetabolic and can rapidly become nutritionally compromised. Malnutrition is prevalent in these patients and has been associated with increased morbidity and mortality. Standard nutrition therapy, i.e. provision of calories, protein and other nutrients consists primarily of enteral nutrition (via a feeding tube into the gastrointestinal tract), parenteral nutrition (via an intravenous tube into the blood), or occasionally a combination of both.
However, the provision of nutrition is sub-optimal and the majority of critically-ill patients do not meet nutritional requirements. Recent studies report that average energy intakes of critically ill patients are only 49% to 70% of calculated requirements. Despite repeated, sustained efforts over the past few years, the investigators have not significantly improved the amount of calories delivered via the enteral route. This leads us to conclude that if the investigators are to be successful at increasing the provision of calories and protein to patients at-risk, the investigators will have to supplement the calories via the parenteral route.
Critically ill patients that are at extremes of weight are at a higher nutritional risk and have higher mortality rates. A recent International multicenter observational study of 2772 ICU patients from 165 ICUs showed a significant inverse linear relationship between the odds of mortality and total daily calories received. Increased amounts of calories was most important for the BMI < 20 group followed by the BMI 20 -< 25 group and BMI > 35 group with no benefit of increased calorie intake for patients in the BMI 25 -< 35 group. Feeding an additional 1000 kcals almost halved the odds of 60-day mortality in patients with a BMI < 25 or > 35. Similar results were observed for feeding an additional 30 grams of protein per day.
Thus, a prospective randomized trial is warranted to confirm our hypothesis that in patients with a BMI of < 25 and those with a BMI > 35 increasing the provision of more energy and protein can impact clinical outcomes. The results of this study will serve to answer some fundamental questions with regards to impact of amount of energy and protein delivered to nutritional at-risk ICU patients and will inform current practice.
Study Intervention:
Patients will be randomized to one of 2 interventions: enteral nutrition alone or enteral nutrition plus parenteral nutrition (supplemental PN group).
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Mechanically ventilated adult patients (≥18 years old) admitted to the ICU
- On or are expected to initiate enteral nutrition within 48 hours from ICU admission
- Are expected to remain mechanically ventilated for more than 72 hours
- Have a BMI < 25 or >35, based on pre-ICU actual or estimated dry weight
Exclusion Criteria:
- >48 hrs from ICU admission to consent
- Not expected to survive an additional 48 hours from screening evaluation
- Lack of commitment to full, aggressive care (anticipated withholding or - withdrawing treatments in the first week but isolated DNR acceptable)
- Patients with an absolute contraindication to EN deemed to require PN for the first 7 days of ICU admission (e.g., GI obstruction or no GI tract access for any reason)
- Already at goal rate of enteral nutrition from screening evaluation (receiving ≥ 60% estimated needs and no evidence of intolerance i.e. high gastric residual volumes, etc)
- Patients already receiving PN on admission to ICU
- Patients admitted with Diabetic Ketoacidosis or non-ketotic hyperosmolar coma
- Pregnant or lactating patients
- Patients with clinical fulminant hepatic failure
- Dedicated port of central line not available
- Known allergy to study nutrients and
- Enrolment in another industry sponsored ICU intervention study (co-enrollment in academic studies will be considered on a case by case basis)
Contacts and Locations| Contact: Rupinder Dhaliwal | 613-549-6666 ext 3830 | dhaliwar@kgh.kari.net |
| United States, Colorado | |
| University of Colorado DHSC | Not yet recruiting |
| Boulder, Colorado, United States, 80045 | |
| Contact: Paul Wischmeyer, MD Paul.Wischmeyer@ucdenver.edu | |
| United States, Oregon | |
| Oregon Health & Science University | Not yet recruiting |
| Portland, Oregon, United States, 97239-3098 | |
| Contact: Bob Martindale martindr@ohsu.edu | |
| United States, Vermont | |
| University of Vermont | Not yet recruiting |
| Burlington, Vermont, United States, 05401 | |
| Contact: Renee Stapleton renee.stapleton@uvm.edu | |
| United States, Wisconsin | |
| University of Wisconsin | Not yet recruiting |
| Madison, Wisconsin, United States, 53705 | |
| Contact: Ken Kudsk kudsk@surgery.wisc.edu | |
| Belgium | |
| Erasme University Hospital | Not yet recruiting |
| Brussels, Belgium, B - 1070 | |
| Contact: Jean-Charles Preiser, MD Jean-Charles.Preiser@erasme.ulb.ac.be | |
| Canada, Alberta | |
| Royal Alexandra Hospital | Recruiting |
| Edmonton, Alberta, Canada, T5H 3V9 | |
| Contact: Jim Kutsogiannis, MD jim.kutsogiannis@ualberta.ca | |
| University of Alberta | Not yet recruiting |
| Edmonton, Alberta, Canada, T5H 3V9 | |
| Contact: Constantine D Karvellas, MD dean.karvellas@ualberta.ca | |
| Grey Nuns Hospital | Not yet recruiting |
| Edmonton, Alberta, Canada, T6L 5X8 | |
| Contact: Dan Stollery dstoller@ualberta.ca | |
| France | |
| Nouvel Hôpital Civil | Not yet recruiting |
| Strasbourg, France, F - 67091 | |
| Contact: Michel Hasselmann, MD michel.hasselmann@chru-strasbourg.fr | |
| Study Chair: | Daren K. Heyland, MD | Clinical Evaluation Research Unit, Kingston General Hospital |
More Information
Additional Information:
Publications:
| Responsible Party: | Dr. D. Heyland, Kingston General Hospital |
| ClinicalTrials.gov Identifier: | NCT01206166 History of Changes |
| Other Study ID Numbers: | TOP-UP |
| Study First Received: | September 14, 2010 |
| Last Updated: | June 23, 2011 |
| Health Authority: | Canada: Health Canada United States: Food and Drug Administration Belgium: Federal Agency for Medicinal Products and Health Products France: Direction Générale de la Santé |
Keywords provided by Clinical Evaluation Research Unit at Kingston General Hospital:
|
Randomized trial Parental nutrition Enteral nutrition Intensive care unit BMI < 25 or ≥ 35 |
Additional relevant MeSH terms:
|
Critical Illness Respiratory Distress Syndrome, Adult Respiratory Insufficiency Overweight Disease Attributes Pathologic Processes |
Lung Diseases Respiratory Tract Diseases Respiration Disorders Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on June 18, 2013